PHC3-PRKACA was classified as ‘cautionary’ PP-SV, as PHC3 showed potential cancer suppressor effect in PCa, while PRKACA appears to portray oncogenic behaviour (Supplementary Table 7). The gene discussed is PRKACA; the disease is posterior cortical atrophy.